317 related articles for article (PubMed ID: 12556246)
21. Impaired glucose metabolism in patients with heart failure: pathophysiology and possible treatment strategies.
Tenenbaum A; Fisman EZ
Am J Cardiovasc Drugs; 2004; 4(5):269-80. PubMed ID: 15449970
[TBL] [Abstract][Full Text] [Related]
22. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Jia G; Hill MA; Sowers JR
Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
[TBL] [Abstract][Full Text] [Related]
23. Early administration of trimetazidine may prevent or ameliorate diabetic cardiomyopathy.
Wenmeng W; Qizhu T
Med Hypotheses; 2011 Feb; 76(2):181-3. PubMed ID: 20932648
[TBL] [Abstract][Full Text] [Related]
24. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
25. Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality.
Parissis JT; Rafouli-Stergiou P; Mebazaa A; Ikonomidis I; Bistola V; Nikolaou M; Meas T; Delgado J; Vilas-Boas F; Paraskevaidis I; Anastasiou-Nana M; Follath F
Int J Cardiol; 2012 May; 157(1):108-13. PubMed ID: 22178056
[TBL] [Abstract][Full Text] [Related]
26. Can the onset of heart failure be delayed by treating diabetic cardiomyopathy?
Marcinkiewicz A; Ostrowski S; Drzewoski J
Diabetol Metab Syndr; 2017; 9():21. PubMed ID: 28396699
[TBL] [Abstract][Full Text] [Related]
27. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
Saha SA; Molnar J; Arora RR
Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
[TBL] [Abstract][Full Text] [Related]
28. Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis.
Castagno D; Baird-Gunning J; Jhund PS; Biondi-Zoccai G; MacDonald MR; Petrie MC; Gaita F; McMurray JJ
Am Heart J; 2011 Nov; 162(5):938-948.e2. PubMed ID: 22093212
[TBL] [Abstract][Full Text] [Related]
29. Ischemic heart disease in type 2 diabetes.
Otel I; Ledru F; Danchin N
Metabolism; 2003 Aug; 52(8 Suppl 1):6-12. PubMed ID: 12939733
[TBL] [Abstract][Full Text] [Related]
30. What have we learned from the current trials?
Abbott KC; Bakris GL
Med Clin North Am; 2004 Jan; 88(1):189-207. PubMed ID: 14871059
[TBL] [Abstract][Full Text] [Related]
31. Importance of risk factor management in diabetic patients and reduction in Stage B heart failure.
Murtagh G; O Connell J; O Connell E; Tallon E; Watson C; Gallagher J; Baugh J; Patle A; O Connell L; Griffin J; O'Hanlon R; Voon V; Ledwidge M; O Shea D; McDonald K
QJM; 2015 Apr; 108(4):307-14. PubMed ID: 25239761
[TBL] [Abstract][Full Text] [Related]
32. Treatment of heart failure in patients with diabetes: clinical update.
Bell DS
Ethn Dis; 2002; 12(1):S1-12-8. PubMed ID: 11915848
[TBL] [Abstract][Full Text] [Related]
33. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
34. Impact of Sex and Diabetes in Patients with Heart Failure.
Álvarez-Zaballos S; Martínez-Sellés M
Curr Heart Fail Rep; 2024 May; ():. PubMed ID: 38698294
[TBL] [Abstract][Full Text] [Related]
35. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
Marwick TH; Ritchie R; Shaw JE; Kaye D
J Am Coll Cardiol; 2018 Jan; 71(3):339-351. PubMed ID: 29348027
[TBL] [Abstract][Full Text] [Related]
36. Impact of diabetes and hypertension on the heart.
Pieske B; Wachter R
Curr Opin Cardiol; 2008 Jul; 23(4):340-9. PubMed ID: 18520718
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure.
Johansson I; Dahlström U; Edner M; Näsman P; Rydén L; Norhammar A
J Am Coll Cardiol; 2016 Sep; 68(13):1404-1416. PubMed ID: 27659462
[TBL] [Abstract][Full Text] [Related]
38. Prevalent Diabetes Mellitus: Mortality and Management in Norwegian Heart Failure Outpatients.
Stubnova V; Os I; Grundtvig M; Waldum-Grevbo B
Cardiology; 2016; 134(4):413-22. PubMed ID: 27120050
[TBL] [Abstract][Full Text] [Related]
39. [Diabetes and heart failure, a fatal association].
Cohen-Solal A; Logeart D
Arch Mal Coeur Vaiss; 2007; 100(6-7):535-46. PubMed ID: 17893636
[TBL] [Abstract][Full Text] [Related]
40. Thiazolidinediones in patients with diabetes mellitus and heart failure : implications of emerging data.
Macfarlane DP; Fisher M
Am J Cardiovasc Drugs; 2006; 6(5):297-304. PubMed ID: 17083264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
